- Home
- CZR vs RYTM Comparison
CZR vs RYTM Comparison
Compare CZR & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZR
- RYTM
- Stock Information
- Founded
- CZR 1937
- RYTM 2008
- Country
- CZR United States
- RYTM United States
- Employees
- CZR N/A
- RYTM N/A
- Industry
- CZR Hotels/Resorts
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- CZR Consumer Discretionary
- RYTM Health Care
- Exchange
- CZR Nasdaq
- RYTM Nasdaq
- Market Cap
- CZR 6.2B
- RYTM 5.9B
- IPO Year
- CZR 1989
- RYTM 2017
- Fundamental
- Price
- CZR $25.33
- RYTM $97.61
- Analyst Decision
- CZR Strong Buy
- RYTM Strong Buy
- Analyst Count
- CZR 14
- RYTM 13
- Target Price
- CZR $42.86
- RYTM $101.92
- AVG Volume (30 Days)
- CZR 6.8M
- RYTM 579.7K
- Earning Date
- CZR 07-29-2025
- RYTM 08-05-2025
- Dividend Yield
- CZR N/A
- RYTM N/A
- EPS Growth
- CZR N/A
- RYTM N/A
- EPS
- CZR N/A
- RYTM N/A
- Revenue
- CZR $11,374,000,000.00
- RYTM $156,287,000.00
- Revenue This Year
- CZR $3.33
- RYTM $37.86
- Revenue Next Year
- CZR $2.50
- RYTM $72.72
- P/E Ratio
- CZR N/A
- RYTM N/A
- Revenue Growth
- CZR N/A
- RYTM 53.55
- 52 Week Low
- CZR $21.40
- RYTM $43.57
- 52 Week High
- CZR $45.93
- RYTM $99.04
- Technical
- Relative Strength Index (RSI)
- CZR 39.64
- RYTM 73.48
- Support Level
- CZR $23.62
- RYTM $95.30
- Resistance Level
- CZR $25.83
- RYTM $99.04
- Average True Range (ATR)
- CZR 0.98
- RYTM 3.21
- MACD
- CZR -0.08
- RYTM 0.20
- Stochastic Oscillator
- CZR 29.64
- RYTM 90.50
About CZR Caesars Entertainment Inc.
Caesars Entertainment includes about 50 domestic gaming properties across the Las Vegas (49% of 2024 EBITDAR before corporate expenses) and regional (46%) markets. Additionally, the company hosts managed properties and digital assets that produced marginal EBITDA in 2024. Caesars' US presence roughly doubled with the 2020 acquisition by Eldorado, which built its first casino in Reno, Nevada, in 1973 and expanded its presence through prior acquisitions to over 20 properties before merging with legacy Caesars. Caesars' brands include Caesars, Harrah's, Tropicana, Bally's, Isle, and Flamingo. Also, the company owns the US portion of William Hill (it sold the international operation in 2022), a digital sports betting platform.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.